ArticleBiomedical reports2025

Plasma IFN-γ may predict pyrotinib efficacy in patients with HER2-positive advanced breast cancer.

Jinghao Jia et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.